RhoA localization with caveolin-1 regulates vascular contractions to serotonin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 9, 2012, Pages

  Nuno, Daniel W ^a,b   England, Sarah K ^b,c   Lamping, Kathryn G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Caveolae; Lipid rafts; Rho kinase

Indexed keywords

CAVEOLIN 1; EXOENZYME C3; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; INHIBITION KINETICS; LIPID RAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SMOOTH MUSCLE CONTRACTION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; AORTA; ARTERIES; CAVEOLIN 1; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SEROTONIN; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 84868352478     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00667.2011     Document Type: Article

References (41)

1. 2+ sensitization by PKC and rho proteins in ovine cerebral arteries: effects of artery size and age. Am J Physiol Heart Circ Physiol 275: H930-H939, 1998.
2. Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem 279: 34614-34623, 2004.
3. Chrissobolis S, Sobey C. Evidence that rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension. Circ Res 88: 774-779, 2001.
4. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
5. Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 22: 1267-1272, 2002.
6. Dubroca C, Loyer X, Retailleau K, Loirand G, Pacaud P, Feron O, Balligand JL, Levy BI, Heymes C, Henrion D. RhoA activation and interaction with caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc Res 73: 190-197, 2007.
7. Feron O, Kelly RA. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ Res 88: 129-131, 2001.
8. Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 106: 403-411, 2001.
9. Harder T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipidcholesterol microdomains. Curr Opin Cell Biol 9: 534-542, 1997.
10. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, Takeshita A. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1+. Circulation 101: 1319-1323, 2000.
11. Lemaire-Ewing S, Lagrost L, Neel D. Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis. Atherosclerosis 221: 303-310, 2012.
12. Li S, Couet J, Lisanti MP. Src tyrosine kinases, G subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996.
13. 2+ imaging of real-time confocal microscopy: variances by artery size and organ specificity. Arch Histol Cytol 71: 291-302, 2008.
14. Miyata K, Shimokawa H, Kandabashi T, Higo T, Morishige K, Eto Y, Egashira K, Kaibuchi K, Takeshita A. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol 20: 2351-2358, 2000.
15. Morris JB, Huynh H, Vasilevski O, Woodcock EA. Alpha1-adrenergic receptor signaling is localized to caveolae in neonatal rat cardiomyocytes. J Mol Cell Cardiol 41: 17-25, 2006.
16. Munro S. Lipid rafts: elusive or illusive? Cell 115: 377-388, 2003.
17. Murata T, Lin M, Huang Y, Yu J, Bauer P, Giordano F, Sessa W. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204: 2373-2382, 2007.
18. 2+ entry by store depletion or hypoxia in canine pulmonary arterial smooth muscle cells. Br J Pharmacol 152: 101-111, 2007.
19. Nuno D, Lamping K. The role of rho kinase in sex-dependent vascular dysfunction in Type 1 diabetes. Exp Diabetes Res 2010: 176361, 2010.
20. Nuno DW, Harrod JS, Lamping KG. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 297: H1469-H1477, 2009.
21. Nuno DW, Korovkina VP, England SK, Lamping KG. RhoA activation contributes to sex differences in vascular contractions. Arterioscler Thromb Vasc Biol 27: 1934-1940, 2007.
22. Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, Ohno S, Couet J, Lisanti MP, Ishikawa Y. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 272: 33416-33421, 1997.
23. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
24. Rahman A, Sward K. The role of caveolin-1 in cardiovascular regulation. Acta Physiol (Oxf) 195: 231-245, 2009.
25. Ryan MJ, Didion SP, Davis DR, Faraci FM, Sigmund CD. Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arterioscler Thromb Vasc Biol 22: 42-48, 2002.
26. Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of rho-kinasemediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87: 195-200, 2000.
27. Satoh KMD, Fukumoto Y, Shimokawa H. Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 301: H287-H296, 2011.
28. Shakirova Y, Bonnevier J, Albinsson S, Adner M, Rippe B, Broman J, Arner A, Sward K. Increased Rho activation and PKC-mediated smooth muscle contractility in the absence of caveolin-1. Am J Physiol Cell Physiol 291: C1326-C1335, 2006.
29. Shaul PW, Anderson RG. Role of plasmalemmal caveolae in signal transduction. Am J Physiol Lung Cell Mol Physiol 275: L843-L851, 1998.
30. Shimokawa H, Morishige K, Miyata K, Kandabashi T, Eto Y, Ikegaki I, Asano T, Kaibuchi K, Takeshita A. Long-term inhibition of rhokinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res 51: 169-177, 2001.
31. Siddiqui MR, Komarova YA, Vogel SM, Gao X, Bonini MG, Rajasingh J, Zhao YY, Brovkovych V, Malik AB. Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability. J Cell Biol 193: 841-850, 2011.
32. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 387: 569-572, 1997.
33. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996.
34. Sowa G, Pypaert M, Sessa WC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 98: 14072-14077, 2001.
35. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
36. Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 274: 12702-12709, 1999.
37. Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X, Surks HK. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res 104: 531-540, 2009.
38. Waugh MG, Lawson D, Hsuan JJ. Epidermal growth factor receptor activation is localized within low-buoyant density, non-caveolar membrane domains. Biochem J 337: 591-597, 1999.
39. Waugh MG, Minogue S, Anderson JS, dos Santos M, Hsuan JJ. Signalling and non-caveolar rafts. Biochem Soc Trans 29: 509-511, 2001.
40. Yamamoto M, Toya Y, Jensen RA, Ishikawa Y. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp Cell Res 247: 380-388, 1999.
41. Yuan T, Hong S, Yao Y, Liao K. Glut-4 is translocated to both caveolae and non-caveolar lipid rafts, but is partially internalized through caveolae in insulin-stimulated adipocytes. Cell Res 17: 772-782, 2007.